The first-ever Cannabis Europa in Spain, saw senior government officials, leading scientists and international press discuss the most pertinent questions for the Spanish and European cannabis industry.
Spain represents Europe’s largest cannabis market yet to legalise medical cannabis. However, with strong social support fueling a shift in the political debate and changes abound across the continent, reform is inevitable. With 84% of the population in favour of medical cannabis, a burgeoning commercial industry and one of the most innovative biomedical sectors in the world, Spain is fast becoming the most promising industry in the region.
Our speakers are global thought-leaders driving change in policy, research, and commerce. Hear their insights, challenge your thinking, and leave with actionable strategies.
Subscribe to receive the latest updates on cannabis regulation, investment, and innovation in Europe.
Join the leading voices in cannabis policy and business. We’re proud to partner with organisations at the forefront of cannabis innovation, investment, and regulation.
Cannabis Europa brings together the brightest minds in cannabis policy, business, and investment. Over two days in London, you’ll engage with policymakers, investors, scientists, and entrepreneurs to explore opportunities in one of the world’s fastest-evolving markets.
Cannabis Europa Paris 2026 – France’s Moment Has Arrived Cannabis Europa Paris 2026 Full Framework Edges Closer 📍 Paris, France February 19, 2026 🎯 Industry Leaders Policy • Innovation • Growth French Market Insight France Extends Medical Cannabis Access Again – Patients To Continue Receiving Treatment Thousands of French medical cannabis patients will continue to […]
On 31 March 2026, France will shut the door on its five-year medical cannabis pilot. On 1 April, the country enters a permanent, pharmaceutical-style regime — one that will determine access, pricing, supply, and prescriber rights for the next decade. For an industry long locked out of France, this moment is arguably more consequential than […]
Following the adoption of the CanG and the associated MedCanG Act, the German medical cannabis market is witnessing significant growth, with German medical cannabis sales expected to reach €420 million in 2024, rising to over €1 billion by 2028. Published today in The German Cannabis Report by Prohibition Partners, this projection is fueled by several factors, including […]
The second day of Cannabis Europa London 2023 began with a look back at the early beginnings of the cannabis business, following an engaging first day of panels centered on the sector’s future. Raphael Mechoulam, the ‘Father of Cannabis Research,’ who passed away in March at the age of 92, was honoured before the opening […]
